|
Mr. Sussman is Managing Partner of The Channel Group, LLC, a life sciences venture formation and management firm. Previously, he served as a member of senior management (Head of Business Development, CFO, and CEO) of several public and private biotechnology companies, including Perlegen Sciences, Inc., Memory Pharmaceuticals Corp., and Cadus Pharmaceutical Corp. Prior to his joining the biotechnology industry, he was Director of Strategy & Business Development at Ciba-Geigy Corp.'s Pharmaceutical Division (now Norvartis AG). He currently is an advisor to PsychoGenics Inc., Automated Cell, Inc., and SCIUS Capital Group LLC. For over ten years, Mr. Sussman was a member of the Review Panel for the Innovative Technology Research Grant Program, Center for Biotechnology, New York State Science and Technology Foundation. He has a B.S. in Physics from SUNY Stony Brook, an M.S. in Biotechnology from Manhattan College, and a Masters Degree in Finance from the Sloan School of Management, MIT. | 